NHS waiting lists around England, updated for January 2018.
NHS England’s flagship cancer drugs fund had spent just over a quarter of its budget halfway through this financial year, amid questions over its long term future.
Cancer patients in three counties are at greater risk of death than elsewhere in the country because of slow referrals and late diagnosis, official data reveals.
NHS waiting lists around England, updated for December 2017.
NHS waiting lists around England, updated for November 2017.
Dame Fiona Caldicott has warned the government that too many exceptions to the new patient data opt out scheme risk repeating the failings of Care.data.
Workforce shortages across cancer care are having a direct impact on the treatment of patients, Cancer Research UK has warned ahead of the publication of a major NHS workforce strategy for the sector.
NHS England has warned that elective waiting time standards “will not be fully funded and met” next year unless there are cuts to services such as mental health, cancer and primary care.
The Care Quality Commission has launched a national review of radiology capacity after it found “significant backlogs of radiology reporting in some trusts.”
Public Health England could move potentially millions of patients’ personal data to an NHS “safe haven” – but will likely retain control of the cancer registry for now, the Department of Health has said.
NHS waiting lists around England, updated for September 2017.
The elective waiting list will balloon to 5 million patients by 2021 and ambitions to improve mental health and cancer care will be jeopardised unless the NHS gets a major funding boost in line with pre-2010 increases, Simon Stevens has warned.
An investigation into the unprecedented WannaCry cyberattack on the NHS has revealed more than 130 urgent cancer referrals were cancelled and more than 1,000 medical devices were infected.
A major teaching trust is pulling its oncology consultants out of two neighbouring hospitals because of longstanding concerns about their “operational standards” – meaning the service will close this month.
The UK’s two leading cancer charities have written to Jeremy Hunt to raise concerns that changes to patient data opt-outs may put at risk the ability to deliver a cornerstone of the national cancer strategy.
A senior clinician leading a national drive against unwarranted variation in the NHS says cancer targets and surgeon mortality rates are “politically derived measures” that may reduce care quality.
An outstanding-rated trust and a royal college have said NHS England would be doing a “disservice” to patients if it withdraws “unique” pain medication under its new savings plan.
A controversial tender for cancer services in Staffordshire worth £687m has been abandoned after a consortium led by a private provider failed to convince commissioners its offer was financially viable.
NHS England has acknowledged that the service is unlikely to hit the 18 week elective waiting time target in the next two years.
NHS trusts will not be penalised for missing waiting targets in the last three months of 2016-17, as part of new efforts to curb the financial deficit.